NSMCE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.121600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.013400E-01
Normal-vs-Stage2
6.314800E-01
Normal-vs-Stage3
8.887800E-01
Normal-vs-Stage4
3.627400E-01
Stage1-vs-Stage2
2.430400E-01
Stage1-vs-Stage3
9.420000E-01
Stage1-vs-Stage4
5.162600E-01
Stage2-vs-Stage3
4.126600E-01
Stage2-vs-Stage4
9.884600E-01
Stage3-vs-Stage4
6.567400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.543000E-01
Normal-vs-AfricanAmerican
5.309000E-01
Normal-vs-Asian
5.043000E-01
Caucasian-vs-AfricanAmerican
7.184200E-01
Caucasian-vs-Asian
3.510600E-01
AfricanAmerican-vs-Asian
7.903800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.119000E-01
Normal-vs-Female
7.151800E-01
Male-vs-Female
9.190200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.284600E-01
Normal-vs-Age(41-60Yrs)
7.958000E-01
Normal-vs-Age(61-80Yrs)
7.200000E-01
Normal-vs-Age(81-100Yrs)
2.330800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.212400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.842440E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.316300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.113200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.673600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.758200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.150200E-01
Normal-vs-Daily Drinker
6.050200E-01
Normal-vs-Weekly Drinker
7.404600E-01
Normal-vs-Occasional Drinker
5.218800E-01
Normal-vs-Social Drinker
7.401000E-01
Non Drinker-vs-Daily Drinker
4.273400E-01
Non Drinker-vs-Weekly Drinker
8.759000E-01
Non Drinker-vs-Occasional Drinker
4.292200E-01
Non Drinker-vs-Social Drinker
7.042000E-01
Daily Drinker-vs-Weekly Drinker
6.084600E-01
Daily Drinker-vs-Occasional Drinker
9.613400E-01
Daily Drinker-vs-Social Drinker
7.952200E-01
Weekly Drinker-vs-Occasional Drinker
5.883600E-01
Weekly Drinker-vs-Social Drinker
8.425600E-01
Occasional Drinker-vs-Social Drinker
8.138200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.358200E-01
Normal-vs-Grade 2
2.883100E-03
Normal-vs-Grade 3
3.536000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.532000E-02
Grade 1-vs-Grade 3
2.921800E-02
Grade 1-vs-Grade 4
2.358200E-01
Grade 2-vs-Grade 3
4.171600E-01
Grade 2-vs-Grade 4
2.883100E-03
Grade 3-vs-Grade 4
3.536000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.087400E-01
Normal-vs-NonDiabetic
6.371800E-01
Diabetic-vs-NonDiabetic
8.753600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.296400E-01
Normal-vs-NoPancreatitis
6.962600E-01
Pancreatitis-vs-NoPancreatitis
1.499000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.574400E-01
Normal-vs-N1
7.025200E-01
N0-vs-N1
2.898000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.285800E-01
Normal-vs-TP53-NonMutant
6.953800E-01
TP53-Mutant-vs-TP53-NonMutant
1.87310999999468E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
